Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |

Takeaways from MAG Silver's Annual Event at PDAC

A Macquarie report discussed a handful of highlights from management's presentation. In a March 6 research note, Macquarie analyst Michael Gray reported the key points from MAG Silver Corp.'s (MAG:TSX; MAG:NYSE.MKT) technical luncheon at the PDAC Conference. MAG Pre...
Streetwise Reports | March 18, 2019 |

Analyst: U.S. Miner's 'Nevada Guidance Lowered, Longer-Term Outlook Unclear'

The company's cost cutting efforts are addressed in a CIBC report. In a June 6 research note, CIBC analyst Cosmos Chiu reported that Hecla Mining Co. (HL:NYSE) lowered 2019 guidance for its Nevada assets "but offered few insights into a longer-term sol...
Streetwise Reports | June 14, 2019 |

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...
Streetwise Reports | November 12, 2019 |

Biopharma Continues 'Positive Push Forward in Breast Cancer'

The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report. In a Dec. 26 research note, analyst Joseph Pantginis reported that H.C. Wainwright & Co. increased its target price to AU$0.20 from AU$0.16 and maintained its Buy recommen...
Streetwise Reports | December 30, 2019 |

Gold Producer to Sell Interest in Founding Asset

The transaction is briefly reviewed and assessed in a BMO Capital Markets report. In a Dec. 23 research note, BMO Capital Markets analyst Jackie Przybylowski reported that IAMGOLD Corp. (IMG:TSX; IAG:NYSE) agreed to sell its 41% interest in the Sadiola gold project ...
Streetwise Reports | January 3, 2020 |

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis

Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. In a June 1 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Enlivex Therapeutics Ltd.'s ...
Streetwise Reports | June 4, 2020 |

Biotech's New Mesothelioma Trial Data Show Efficacy, Immunogenicity

These results of a study evaluating Targovax's lead candidate are reviewed and commented on in an H.C. Wainwright & Co. report. In a June 22 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Targovax ASA's (TRVX:OSE) ONCOS-102, in trial ...
Streetwise Reports | June 25, 2020 |

Buzz on the Bullboards: New energy, heath, and transport opportunities

Canada’s largest financial portal for Canadian small-cap investors is right here at Stockhouse. It is where our Bullboards – your Bullboards – are a leading forum to discuss these Canadian-listed small-cap businesses. Stocks on both sides of the border...
Jonathon Brown | October 19, 2023 |

Is Canopy Growth a good stock to buy?

Canopy Growth Corp. (TSX:WEED) holds a prominent position in the Canadian cannabis industry, but is it a good stock to buy? Initially, the stock experienced remarkable growth, driven by the anticipation surrounding the legalization of recreational cannabis in ...
Jonathon Brown | December 13, 2023 |
1 2 3